JP Morgan Chase
TWST icon

JP Morgan Chase’s Twist Bioscience TWST Stock Holding History

JP Morgan Chase’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,200
Closed -$207K – 7686
2024
Q2 		$207K Buy
+4,200
New +$171K ﹤0.01% 5151

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase's TWST Position: Q1 2026 in Review

JP Morgan Chase reduced its Twist Bioscience (TWST) stake by 4.4% in Q1 2026, selling an estimated $421K and leaving 205,767 shares worth $8.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

JP Morgan Chase first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. The position peaked at $256M in Q4 2020. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • JP Morgan Chase held 205,767 shares of Twist Bioscience worth $8.9M as of Q1 2026.
  • JP Morgan Chase sold 9,380 Twist Bioscience shares in Q1 2026, an estimated $421K.
  • Twist Bioscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2795 holding.
  • JP Morgan Chase first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
  • JP Morgan Chase's Twist Bioscience position peaked at $256M in Q4 2020.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.